百济神州(BGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BGNE 百济神州

盘后交易 12-11 17:51:00 EST

174.54

-0.46

-0.26%

盘后174.49

-0.05-0.03%

17:10 EST

最高174.86	最低171.23	成交量24.85万
今开174.00	昨收175.00	日振幅2.07%
总市值181.80亿	流通市值100.75亿	总股本1.04亿
成交额4,311万	换手率0.43%	流通股本5,773万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BGNE","market":"US","secType":"STK","nameCN":"百济神州","latestPrice":174.54,"timestamp":1702328400000,"preClose":175,"halted":0,"volume":248535,"hourTrading":{"tag":"盘后","latestPrice":174.49,"preClose":174.54,"latestTime":"17:10 EST","volume":1130,"amount":197230.1435,"timestamp":1702332610008},"delay":0,"floatShares":57725509,"shares":104161985,"eps":-9.279483,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.46,"latestTime":"12-11 17:51:00 EST","open":174,"high":174.86,"low":171.23,"amount":43112240.58645,"amplitude":0.020743,"askPrice":174.49,"askSize":68,"bidPrice":172.54,"bidSize":400,"shortable":3,"etf":0,"ttmEps":-9.279483,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1702342800000},"adr":1,"adjPreClose":175,"adrRate":13,"preHourTrading":{"tag":"盘前","latestPrice":175.01,"preClose":175,"latestTime":"09:28 EST","volume":60,"amount":10500.599999999999,"timestamp":1702304885058},"postHourTrading":{"tag":"盘后","latestPrice":174.49,"preClose":174.54,"latestTime":"17:10 EST","volume":1130,"amount":197230.1435,"timestamp":1702332610008},"volumeRatio":1.367168},"requestUrl":"/m/hq/s/BGNE","defaultTab":"news","newsList":[{"id":"2390180336","title":"最新公布! 百济神州(06160)泽布替尼在头对头研究中取得持续获益的随访数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2390180336","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2390180336?lang=zh_cn&edition=full","pubTime":"2023-12-11 16:21","pubTimestamp":1702282870,"startTime":"0","endTime":"0","summary":"百济神州公布自主研发抗癌药物泽布替尼(百悦泽®)治疗复发或难治性慢性淋巴细胞白血病(CLL)/小淋巴细胞淋巴瘤(SLL)患者的长期随访数据。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20231211/20231211162229_21666.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20231211/20231211162229_21666.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1036211.html","is_publish_highlight":false},{"id":"2390338812","title":"百济神州(06160)下跌5.06%，报101.3元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2390338812","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2390338812?lang=zh_cn&edition=full","pubTime":"2023-12-11 10:59","pubTimestamp":1702263565,"startTime":"0","endTime":"0","summary":"12月11日，百济神州(06160)盘中下跌5.06%，截至10:59，报101.3元/股，成交5551.32万元。百济神州有限公司是一家专注于开发和商业化用于治疗癌症的创新型分子靶向和肿瘤免疫治疗药物的生物技术公司。公司拥有包括六种内部开发的临床阶段候选药物和五种获得授权许可的药物在内的广泛产品组合，以及超过1300名员工的全球团队。截至2023年三季报，百济神州营业总收入130.99亿元、净利润-36.92亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2023/12/11105938724246.shtml","is_publish_highlight":false},{"id":"2390680092","title":"百济神州-U盘中异动 股价大跌5.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2390680092","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2390680092?lang=zh_cn&edition=full","pubTime":"2023-12-11 10:34","pubTimestamp":1702262067,"startTime":"0","endTime":"0","summary":"2023年12月11日早盘10时34分，百济神州-U出现异动，股价大幅下跌5.0%。截至发稿，该股报154.00元/股，成交量1.178万手，换手率1.07%，振幅5.74%，量比2.08。机构评级方面，近半年内1家券商给予增持建议，14家券商给予买入建议。过去一年内该股还未有涨停，也没有跌停。百济神州-U公司主营业务为研究、开发、生产以及商业化创新型药物截至2023年12月11日，该公司股东人数（户）为40908，较上个统计日减少2941户。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121110343083ed6913&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121110343083ed6913&s=b","is_publish_highlight":false},{"id":"2390041278","title":"北向资金12月8日净卖出百济神州-U75.16万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2390041278","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2390041278?lang=zh_cn&edition=full","pubTime":"2023-12-11 09:30","pubTimestamp":1702258236,"startTime":"0","endTime":"0","summary":"12月8日，北向资金减持百济神州-U75.16万股连续3日减持。截止当日收盘，沪股通共持有百济神州-U64.51万股，占流通股0.58%。沪股通减持金额前五个股分别为联影医疗、海光信息、中国太保、中国银行、华大智造。百济神州-U近5个交易日上涨5.23%，沪股通累计减持88.83万股；近20个交易日上涨8.88%，沪股通累计减持32.40万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121109390083ed3a38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121109390083ed3a38&s=b","is_publish_highlight":false},{"id":"2390589445","title":"百济神州获机构上调今年盈利 机构预计牧原股份今年将亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2390589445","media":"21经济网","top":-1,"share":"https://www.laohu8.com/m/news/2390589445?lang=zh_cn&edition=full","pubTime":"2023-12-09 09:17","pubTimestamp":1702084668,"startTime":"0","endTime":"0","summary":"百济神州获机构上调，今年亏损收窄本周市场回调明显，机构对今年盈利预测值“再评估”的热情降至“冰点”。此前贺菊颖在8月16日的发表的研报中预计其今年亏损103.34亿元，按此计算其本次上调百济神州今年盈利预测值幅度达到了35.48%。机构调整牧原股份盈利预测值由盈转亏被下调今年盈利预测值公司中，“猪茅”之称的牧原股份遭下调幅度居首位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120909291083e64069&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120909291083e64069&s=b","is_publish_highlight":false},{"id":"2389855180","title":"百济神州(06160)与王晓东订立咨询协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2389855180","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2389855180?lang=zh_cn&edition=full","pubTime":"2023-12-08 19:44","pubTimestamp":1702035848,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)公布，2023年12月7日(北京时间)，公司就 Xiaodong Wang(王晓东)博士将于自 2024 年 1 月 1 日起至 2026 年 12 月 31 日止期间提供的服务与王博士订立咨询协议。根据该协议，王博士作为顾问每年收取的薪酬包括：(1) 10万美元的固定咨询费;及(2)公司可全权酌情决定的额外薪酬(如有)，但须符合所适用的证券交易所上市规则。此外，经与王博士协商一致，公司可不时调整该等咨询费及额外薪酬(如有)，但须遵守任何所适用的法律、监管要求或证券交易所上市规则。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1035703.html","is_publish_highlight":false},{"id":"2389853071","title":"百济神州下跌2.01%，报178.32美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2389853071","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2389853071?lang=zh_cn&edition=full","pubTime":"2023-12-08 03:19","pubTimestamp":1701976792,"startTime":"0","endTime":"0","summary":"12月8日，百济神州(BGNE)盘中下跌2.01%，截至03:19，报178.32美元/股，成交926.39万美元。财务数据显示，截至2023年09月30日，百济神州收入总额18.24亿美元，同比增长76.13%；归母净利润-5.14亿美元，同比增长67.01%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2023/12/08031938703870.shtml","is_publish_highlight":false},{"id":"2389042371","title":"百济神州(06160)：约460.22万股限售股将于12月15日起上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2389042371","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2389042371?lang=zh_cn&edition=full","pubTime":"2023-12-07 18:53","pubTimestamp":1701946424,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)公布，约460.22万股限售股将于 2023 年 12 月 15 日起上市流通。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1035012.html","is_publish_highlight":false},{"id":"2389270647","title":"百济神州上涨2.01%，报184.81美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2389270647","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2389270647?lang=zh_cn&edition=full","pubTime":"2023-12-06 03:13","pubTimestamp":1701803624,"startTime":"0","endTime":"0","summary":"12月6日，百济神州(BGNE)盘中上涨2.01%，截至03:13，报184.81美元/股，成交1952.47万美元。财务数据显示，截至2023年09月30日，百济神州收入总额18.24亿美元，同比增长76.13%；归母净利润-5.14亿美元，同比增长67.01%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2023/12/06031338679702.shtml","is_publish_highlight":false},{"id":"2389771737","title":"百济神州(06160)授出可认购合共2536股美国存托股份的购股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2389771737","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2389771737?lang=zh_cn&edition=full","pubTime":"2023-12-05 17:35","pubTimestamp":1701768939,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2023年11月30日，董事会薪酬委员会根据2016期权及激励计划的条款授予二名承授人可认购合共2536股美国存托股份的购股权。已授出购股权的行使价为每股美国存托股份186.94美元(约每股普通股112.16港元)。于2023年11月30日，董事会薪酬委员会根据2016期权及激励计划的条款授予183名承授人合共6.28万股美国存托股份受限制股份单位。该等受限制股份单位相当于81.65万股股份，约占本公告之日公司发行股份总数的0.06%。美国存托股份于授出日期的收市价为每股美国存托股份186.94美元(约每股普通股112.16港元)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1033647.html","is_publish_highlight":false},{"id":"2389203760","title":"百济神州12月4日获南向资金加仓28.64万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2389203760","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2389203760?lang=zh_cn&edition=full","pubTime":"2023-12-05 09:31","pubTimestamp":1701739890,"startTime":"0","endTime":"0","summary":"12月4日, 南向资金增持百济神州28.64万股。截止当日收盘，港股通共持有百济神州5572.68万股，占流通股4.09%。百济神州近5个交易日下跌1.26%，港股通累计增持77.69万股；近20个交易日下跌11.26%，港股通累计增持770.98万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231205094732822eae98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231205094732822eae98&s=b","is_publish_highlight":false},{"id":"2388568215","title":"一个月内3款国产药出海，它们的机会在哪里？","url":"https://stock-news.laohu8.com/highlight/detail?id=2388568215","media":"虎嗅APP","top":-1,"share":"https://www.laohu8.com/m/news/2388568215?lang=zh_cn&edition=full","pubTime":"2023-12-02 21:24","pubTimestamp":1701523440,"startTime":"0","endTime":"0","summary":"在不到一个月内，有三款中国新药获美国食品和药品管理局批准上市。这也是2019年百济神州的泽布替尼实现零的突破以来，最密集的一次中国新药出海里程碑事件。越来越多成功出海的中国新药背后，另一个难题也已经呼之欲出，那就是大部分国产新药，在中国商业化表现尚且欠佳，在竞争更加激烈的国际市场上，他们的机会又在哪里？为了稳住这个价格，大药厂们也不会轻易在全球其他地区降价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MTQzMjE1NjQwMQ==&mid=2655966788&idx=3&sn=c32786e2bb5728805bf791927016bc5a&chksm=66d979da51aef0cca1e295060a07730be624866bf0a3fb26dbbbc6d4164e99323f033f2c2f7f&scene=0#rd","is_publish_highlight":false},{"id":"2388472567","title":"百济神州(06160)因受限制股份单位获归属发行36.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2388472567","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2388472567?lang=zh_cn&edition=full","pubTime":"2023-12-01 08:10","pubTimestamp":1701389430,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2023年11月30日，因根据股权计划授出的受限制股份单位获归属(公司董事除外)而发行36.1万股;因合资格参与者(公司董事除外)于2023年11月1日至2023年11月30日期间行使购股权而发行合计26.57万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1031963.html","is_publish_highlight":false},{"id":"2387621324","title":"北向资金11月29日净买入百济神州-U8.83万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2387621324","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2387621324?lang=zh_cn&edition=full","pubTime":"2023-11-30 09:30","pubTimestamp":1701307837,"startTime":"0","endTime":"0","summary":"11月29日, 北向资金增持百济神州-U8.83万股，连续3日增持。截止当日收盘，沪股通共持有百济神州-U147.63万股，占流通股1.33%。沪股通增持金额前五个股分别为贵州茅台、海光信息、联影医疗、人福医药、华泰证券。百济神州-U近5个交易日上涨3.50%，沪股通累计增持78.77万股；近20个交易日上涨1.58%，沪股通累计增持84.36万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231130093737821b2840&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231130093737821b2840&s=b","is_publish_highlight":false},{"id":"2387646650","title":"百济神州(06160)因受限制股份单位获归属发行18.72万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2387646650","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2387646650?lang=zh_cn&edition=full","pubTime":"2023-11-30 07:46","pubTimestamp":1701301560,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2023年11月29日，因根据股权计划授出的受限制股份单位获归属(公司董事除外)而发行18.72万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1031249.html","is_publish_highlight":false},{"id":"2387564104","title":"不走寻常路？百济神州13.3亿美元引进CDK2抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2387564104","media":"经济观察网","top":-1,"share":"https://www.laohu8.com/m/news/2387564104?lang=zh_cn&edition=full","pubTime":"2023-11-29 15:05","pubTimestamp":1701241500,"startTime":"0","endTime":"0","summary":"近日，百济神州宣布与昂胜医药达成合作，获得后者差异化CDK2抑制剂ETX-197的全球独家授权，Ensem将获得一笔未披露的预付款以及后期里程碑付款，总额高达13.3亿美元。数据显示，全球乳腺癌药物市场规模2022年已达315亿美元，其中HER2靶向药物和CDK4/6抑制剂占比最多。目前的临床研究结果表明，PF-07104091单药治疗具有良好耐受性，且针对CDK4/6抑制剂耐药后的HR+/HER2-MBC具有良好疗效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023112915062583096ff5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023112915062583096ff5&s=b","is_publish_highlight":false},{"id":"2386995111","title":"百济神州将在2023年美国血液学会年会公布新数据 展示血液学产品组合及管线优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2386995111","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2386995111?lang=zh_cn&edition=full","pubTime":"2023-11-28 19:10","pubTimestamp":1701169800,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局近日授予sonrotoclax用于治疗多发性骨髓瘤的孤儿药资格认定。提升对精神健康及癌症护理重要性的认知 百济神州将在ASH会议期间举办公司第二次以关注肿瘤患者精神健康为主题的年度活动。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4278812_ZH78812_1","is_publish_highlight":false},{"id":"2386416314","title":"百济神州-U11月27日获北向资金加仓52.35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2386416314","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2386416314?lang=zh_cn&edition=full","pubTime":"2023-11-28 09:30","pubTimestamp":1701135033,"startTime":"0","endTime":"0","summary":"11月27日, 北向资金增持百济神州-U52.35万股。截止当日收盘，沪股通共持有百济神州-U122.34万股，占流通股1.10%。沪股通增持金额前五个股分别为海光信息、联影医疗、药明康德、龙芯中科、中国太保。百济神州-U近5个交易日上涨4.37%，沪股通累计增持42.36万股；近20个交易日上涨2.51%，沪股通累计增持60.51万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231128093648844bf7a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231128093648844bf7a2&s=b","is_publish_highlight":false},{"id":"2386922158","title":"百济神州下跌2.05%，报180.94美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2386922158","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2386922158?lang=zh_cn&edition=full","pubTime":"2023-11-28 02:49","pubTimestamp":1701110972,"startTime":"0","endTime":"0","summary":"11月28日，百济神州(BGNE)盘中下跌2.05%，截至02:49，报180.94美元/股，成交1189.04万美元。财务数据显示，截至2023年09月30日，百济神州收入总额18.24亿美元，同比增长76.13%；归母净利润-5.14亿美元，同比增长67.01%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2023/11/28024938595073.shtml","is_publish_highlight":false},{"id":"2386959267","title":"百济神州上涨2.11%，报186.64美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2386959267","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2386959267?lang=zh_cn&edition=full","pubTime":"2023-11-25 01:00","pubTimestamp":1700845243,"startTime":"0","endTime":"0","summary":"11月25日，百济神州(BGNE)盘中上涨2.11%，截至01:00，报186.64美元/股，成交2475.77万美元。财务数据显示，截至2023年09月30日，百济神州收入总额18.24亿美元，同比增长76.13%；归母净利润-5.14亿美元，同比增长67.01%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2023/11/25010038565483.shtml","is_publish_highlight":false}],"profile":{"websiteUrl":"http://www.beigene.cn","stockEarnings":[{"period":"1week","weight":-0.0666},{"period":"1month","weight":-0.1259},{"period":"3month","weight":-0.0915},{"period":"6month","weight":-0.19},{"period":"1year","weight":-0.1284},{"period":"ytd","weight":-0.2043}],"compareEarnings":[{"period":"1week","weight":0.0024},{"period":"1month","weight":0.0525},{"period":"3month","weight":0.033},{"period":"6month","weight":0.0705},{"period":"1year","weight":0.1614},{"period":"ytd","weight":0.2034}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BeiGene Ltd是一家全球性生物技术公司。该公司专注于开发和商业化肿瘤药物，以改善治疗效果并扩大全球患者的可及性。该发了三种获批药物，包括用于治疗各种血癌的布鲁顿酪氨酸激酶（BTK）小分子抑制剂RUKINSA；tislelizumab，一种抗PD-1抗体免疫疗法，用于治疗各种实体瘤和血癌和pamiparib，PARP1和PARP2的选择性小分子抑制剂。它已获得在美国、中国、欧盟、英国、加拿大和澳大利亚销售BRUKINSA的批准。该公司已获得在中国市场分销约13种获批药品的权利。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.096684},{"month":2,"riseRate":0.571429,"avgChangeRate":0.002641},{"month":3,"riseRate":0.375,"avgChangeRate":-0.025561},{"month":4,"riseRate":0.5,"avgChangeRate":0.034245},{"month":5,"riseRate":0.5,"avgChangeRate":-0.012888},{"month":6,"riseRate":0.625,"avgChangeRate":0.022561},{"month":7,"riseRate":0.75,"avgChangeRate":0.132564},{"month":8,"riseRate":0.5,"avgChangeRate":0.021799},{"month":9,"riseRate":0.5,"avgChangeRate":0.051436},{"month":10,"riseRate":0.625,"avgChangeRate":0.017618},{"month":11,"riseRate":0.5,"avgChangeRate":0.059889},{"month":12,"riseRate":0.375,"avgChangeRate":-0.027047}],"exchange":"NASDAQ","name":"百济神州","nameEN":"BeiGene"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.19.1","shortVersion":"4.19.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(BGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(BGNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,BGNE,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(BGNE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(BGNE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}